Not all of drug innovations are created equal. Some aren’t better than existing standards of care. Others are breakthroughs. Still others are marginal improvements.
Pharmaceutical Innovativeness Is Highly Varied, As CMS Will Soon Find Out When It Does Comparative Effectiveness Assessments
